Effects of semaglutide on metabolism and gut microbiota in high-fat diet-induced obese mice
BackgroundThe purpose of this study was to explore how semaglutide, a GLP-1RA, regulates serum metabolism and gut microbiota to improve obesity in mice and whether fecal microbiota transplantation (FMT) can transmit the beneficial effects of semaglutide to recipient mice.MethodsMale C57BL/6J mice we...
Saved in:
| Main Authors: | Luyan Sun, Bingqing Shang, Suyuan Lv, Guolong Liu, Qiu Wu, Yue Geng |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1562896/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Both subcutaneous semaglutide and calorie restriction improves pancreatic cell hyperplasia and gut microbiota in high-fat diet-induced obese mice
by: Yunfei Luo, et al.
Published: (2025-08-01) -
Therapeutic effect of fecal microbiota transplantation on hyperuricemia mice by improving gut microbiota
by: Songjian Yuan, et al.
Published: (2025-08-01) -
The Multi-Faceted Role of Gut Microbiota in Alopecia Areata
by: Andrea Severino, et al.
Published: (2025-06-01) -
Fecal microbiota transplantation for hypertension: an exploratory, multicenter, randomized, blinded, placebo-controlled trial
by: Luyun Fan, et al.
Published: (2025-05-01) -
Cardiac function of colorectal cancer mice is remotely controlled by gut microbiota: regulating serum metabolites and myocardial cytokines
by: Zhan-Kui Gao, et al.
Published: (2025-05-01)